Filing metadata

Accession number
0001209191-18-063964
Form type
Form 3
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Dec 21, 2018
Reporting period
Dec 20, 2018
Description
Initial ownership

Explore SEC Filings Hub